Skip to main content
Screener/Healthcare/Biotechnology

NRXP — NRx Pharmaceuticals, Inc.

NASDAQ
$2.27-0.39 (-14.47%)
$1.62
$5.05
$2.11
$2.84
EPS (TTM)$-1.58
P/E Ratio-3.27
Dividend Yield—
Market Cap$103.9M
Volume15.02M
Prev Close$2.66
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$983K$360K$0.0148.3%36.6%
Q3 '25$242K-$5.9M$-0.2759.9%-2433.9%
Q2 '25$0-$17.6M$-0.98——
Q1 '25$0-$5.5M$-0.34——
Q4 '24$0-$9.1M$-0.86——
Q3 '24$0-$1.6M$-0.15——
Q2 '24$0-$7.9M$-0.75——
Q1 '24$0-$6.5M$-0.74——
Get Your Daily Market Recap